{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:24:13Z","timestamp":1792157053116,"version":"4.4.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Genome-wide association studies (GWAS) have indicated moderate genetic overlap between Alzheimer\u2019s disease (AD) and related dementias (ADRD), Parkinson\u2019s disease (PD) and amyotrophic lateral sclerosis (ALS), neurodegenerative disorders traditionally considered etiologically distinct. However, the specific genetic variants and loci underlying this overlap remain almost entirely unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We leveraged state-of-the-art GWAS for ADRD, PD, and ALS. For each pair of disorders, we examined each of the GWAS hits for one disorder and tested whether they were also significant for the other disorder, applying Bonferroni correction for the number of variants tested. This approach rigorously controls the family-wise error rate for both disorders, analogously to genome-wide significance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eleven loci with GWAS hits for one disorder were also associated with one or both of the other disorders: one with all three disorders (the\n                      <jats:italic>MAPT<\/jats:italic>\n                      \/\n                      <jats:italic>KANSL1<\/jats:italic>\n                      locus), five with ADRD and PD (near\n                      <jats:italic>LCORL<\/jats:italic>\n                      ,\n                      <jats:italic>CLU<\/jats:italic>\n                      ,\n                      <jats:italic>SETD1A<\/jats:italic>\n                      \/\n                      <jats:italic>KAT8<\/jats:italic>\n                      ,\n                      <jats:italic>WWOX<\/jats:italic>\n                      , and\n                      <jats:italic>GRN<\/jats:italic>\n                      ), three with ADRD and ALS (near\n                      <jats:italic>GPX3<\/jats:italic>\n                      ,\n                      <jats:italic>HS3ST5<\/jats:italic>\n                      \/\n                      <jats:italic>HDAC2<\/jats:italic>\n                      \/\n                      <jats:italic>MARCKS<\/jats:italic>\n                      , and\n                      <jats:italic>TSPOAP1<\/jats:italic>\n                      ), and two with PD and ALS (near\n                      <jats:italic>GAK<\/jats:italic>\n                      \/\n                      <jats:italic>TMEM175<\/jats:italic>\n                      and\n                      <jats:italic>NEK1<\/jats:italic>\n                      ). Two of these loci (\n                      <jats:italic>LCORL<\/jats:italic>\n                      and\n                      <jats:italic>NEK1<\/jats:italic>\n                      ) were associated with an increased risk of one disorder but decreased risk of another. Colocalization analysis supported a shared causal variant between ADRD and PD at the\n                      <jats:italic>CLU<\/jats:italic>\n                      ,\n                      <jats:italic>WWOX<\/jats:italic>\n                      , and\n                      <jats:italic>LCORL<\/jats:italic>\n                      loci, between ADRD and ALS at the\n                      <jats:italic>TSPOAP1<\/jats:italic>\n                      locus, and between PD and ALS at the\n                      <jats:italic>NEK1<\/jats:italic>\n                      and\n                      <jats:italic>GAK<\/jats:italic>\n                      \/\n                      <jats:italic>TMEM175<\/jats:italic>\n                      loci. To address the concern that ADRD is an imperfect proxy for AD and that the ADRD and PD GWAS have overlapping participants (nearly all of which are from the UK Biobank), we confirmed that all our ADRD associations had nearly identical odds ratios in an AD GWAS that excluded the UK Biobank, and all but one remained nominally significant (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05) for AD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In one of the most comprehensive investigations to date of pleiotropy between neurodegenerative disorders, we identify eleven genetic risk loci shared among ADRD, PD, and ALS. These loci support lysosomal\/autophagic dysfunction (\n                      <jats:italic>GAK<\/jats:italic>\n                      \/\n                      <jats:italic>TMEM175<\/jats:italic>\n                      ,\n                      <jats:italic>GRN<\/jats:italic>\n                      ,\n                      <jats:italic>KANSL1<\/jats:italic>\n                      ), neuroinflammation\/immunity (\n                      <jats:italic>TSPOAP1<\/jats:italic>\n                      ), oxidative stress (\n                      <jats:italic>GPX3<\/jats:italic>\n                      ,\n                      <jats:italic>KANSL1<\/jats:italic>\n                      ), and the DNA damage response (\n                      <jats:italic>NEK1<\/jats:italic>\n                      ) as transdiagnostic processes underlying multiple neurodegenerative disorders.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-023-01244-3","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T04:03:12Z","timestamp":1686888192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Shared genetic risk loci between Alzheimer\u2019s disease and related dementias, Parkinson\u2019s disease, and amyotrophic lateral sclerosis"],"prefix":"10.1186","volume":"15","author":[{"given":"Michael","family":"Wainberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shea J.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreejoy J.","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"key":"1244_CR1","doi-asserted-by":"publisher","unstructured":"Brittany N. Dugger DWD. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2017;9(7). https:\/\/doi.org\/10.1101\/cshperspect.a028035.","DOI":"10.1101\/cshperspect.a028035"},{"issue":"10","key":"1244_CR2","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/s41593-018-0240-z","volume":"21","author":"PL De Jager","year":"2018","unstructured":"De Jager PL, Yang HS, Bennett DA. Deconstructing and targeting the genomic architecture of human neurodegeneration. Nat Neurosci. 2018;21(10):1310\u20137.","journal-title":"Nat Neurosci"},{"key":"1244_CR3","doi-asserted-by":"publisher","unstructured":"Boyle PA, Yu L, Wilson RS, Leurgans SE, Schneider JA, Bennett DA. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol. 2018;83(1). https:\/\/doi.org\/10.1002\/ana.25123.","DOI":"10.1002\/ana.25123"},{"issue":"8","key":"1244_CR4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41551-020-0593-y","volume":"4","author":"EJ Cornblath","year":"2020","unstructured":"Cornblath EJ, Robinson JL, Irwin DJ, et al. Defining and predicting transdiagnostic categories of neurodegenerative disease. Nature Biomedical Engineering. 2020;4(8):787\u2013800.","journal-title":"Nature Biomedical Engineering"},{"issue":"11","key":"1244_CR5","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1136\/jnnp-2014-308350","volume":"87","author":"RM Ahmed","year":"2016","unstructured":"Ahmed RM, Devenney EM, Irish M, et al. Neuronal network disintegration: common pathways linking neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 2016;87(11):1234\u201341.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1244_CR6","doi-asserted-by":"publisher","unstructured":"Ganguly G, Chakrabarti S, Chatterjee U, Saso L. Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer\u2019s disease and Parkinson\u2019s disease. Drug Des Devel Ther. 2017;11. https:\/\/doi.org\/10.2147\/DDDT.S130514.","DOI":"10.2147\/DDDT.S130514"},{"issue":"10","key":"1244_CR7","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41593-018-0237-7","volume":"21","author":"L Gan","year":"2018","unstructured":"Gan L, Cookson MR, Petrucelli L, La Spada AR. Converging pathways in neurodegeneration, from genetics to mechanisms. Nat Neurosci. 2018;21(10):1300.","journal-title":"Nat Neurosci"},{"key":"1244_CR8","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.biopha.2018.12.101","volume":"111","author":"SH Tan","year":"2019","unstructured":"Tan SH, Karri V, Tay N, et al. Emerging pathways to neurodegeneration: dissecting the critical molecular mechanisms in Alzheimer\u2019s disease, Parkinson\u2019s disease. Biomed Pharmacother. 2019;111:765\u201377.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1244_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42466-019-0039-8","volume":"1","author":"AP Marsh","year":"2019","unstructured":"Marsh AP. Molecular mechanisms of proteinopathies across neurodegenerative disease: a review. Neurological Research and Practice. 2019;1(1):1\u20137.","journal-title":"Neurological Research and Practice"},{"key":"1244_CR10","doi-asserted-by":"publisher","unstructured":"Bellou E, Stevenson-Hoare J, Escott-Price V. Polygenic risk and pleiotropy in neurodegenerative diseases. Neurobiol Dis. 2020;142. https:\/\/doi.org\/10.1016\/j.nbd.2020.104953.","DOI":"10.1016\/j.nbd.2020.104953"},{"key":"1244_CR11","doi-asserted-by":"publisher","unstructured":"Anttila V, Bulik-Sullivan B, Finucane HK, et al. Analysis of shared heritability in common disorders of the brain. Science. 2018;360(6395). https:\/\/doi.org\/10.1126\/science.aap8757.","DOI":"10.1126\/science.aap8757"},{"issue":"9","key":"1244_CR12","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/ng.642","volume":"42","author":"TH Hamza","year":"2010","unstructured":"Hamza TH, Zabetian CP, Tenesa A, et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson\u2019s disease. Nat Genet. 2010;42(9):781\u20135.","journal-title":"Nat Genet"},{"issue":"12","key":"1244_CR13","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45(12):1452.","journal-title":"Nat Genet"},{"issue":"7","key":"1244_CR14","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S1474-4422(14)70065-1","volume":"13","author":"R Ferrari","year":"2014","unstructured":"Ferrari R, Hernandez DG, Nalls MA, et al. Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol. 2014;13(7):686.","journal-title":"Lancet Neurol"},{"issue":"12","key":"1244_CR15","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41588-021-00973-1","volume":"53","author":"W van Rheenen","year":"2021","unstructured":"van Rheenen W, van der Spek RAA, Bakker MK, et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat Genet. 2021;53(12):1636\u201348.","journal-title":"Nat Genet"},{"issue":"12","key":"1244_CR16","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Sim\u00f3n-S\u00e1nchez","year":"2009","unstructured":"Sim\u00f3n-S\u00e1nchez J, Schulte C, Bras JM, et al. Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat Genet. 2009;41(12):1308\u201312.","journal-title":"Nat Genet"},{"issue":"12","key":"1244_CR17","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/mp.2015.6","volume":"20","author":"RS Desikan","year":"2015","unstructured":"Desikan RS, Schork AJ, Wang Y, et al. Genetic overlap between Alzheimer\u2019s disease and Parkinson\u2019s disease at the MAPT locus. Mol Psychiatry. 2015;20(12):1588.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1244_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/mp.2015.23","volume":"21","author":"G Jun","year":"2015","unstructured":"Jun G, Ibrahim-Verbaas CA, Vronskaya M, et al. A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry. 2015;21(1):108\u201317.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1244_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-018-0270-8","volume":"13","author":"JA Chen","year":"2018","unstructured":"Chen JA, Chen Z, Won H, et al. Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases. Mol Neurodegener. 2018;13(1):1\u201311.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"1244_CR20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/ng.536","volume":"42","author":"VM Van Deerlin","year":"2010","unstructured":"Van Deerlin VM, Sleiman PMA, Martinez-Lage M, et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 2010;42(3):234.","journal-title":"Nat Genet"},{"issue":"1","key":"1244_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-020-01883-5","volume":"19","author":"Y Hu","year":"2021","unstructured":"Hu Y, Sun JY, Zhang Y, et al. rs1990622 variant associates with Alzheimer\u2019s disease and regulates TMEM106B expression in human brain tissues. BMC Med. 2021;19(1):1\u201310.","journal-title":"BMC Med"},{"key":"1244_CR22","doi-asserted-by":"crossref","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54:412\u201336.","DOI":"10.1038\/s41588-022-01024-z"},{"key":"1244_CR23","doi-asserted-by":"publisher","unstructured":"Nalls MA, Blauwendraat C, Sargent L, et al. Evidence for GRN connecting multiple neurodegenerative diseases. Brain Communications. 2021;3(2). https:\/\/doi.org\/10.1093\/braincomms\/fcab095.","DOI":"10.1093\/braincomms\/fcab095"},{"issue":"4","key":"1244_CR24","doi-asserted-by":"publisher","first-page":"e1003455","DOI":"10.1371\/journal.pgen.1003455","volume":"9","author":"OA Andreassen","year":"2013","unstructured":"Andreassen OA, Thompson WK, Schork AJ, et al. Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate. PLoS Genet. 2013;9(4):e1003455.","journal-title":"PLoS Genet"},{"issue":"2","key":"1244_CR25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/jnnp-2016-314411","volume":"88","author":"R Ferrari","year":"2017","unstructured":"Ferrari R, Wang Y, Vandrovcova J, et al. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer\u2019s and Parkinson\u2019s diseases. J Neurol Neurosurg Psychiatry. 2017;88(2):152\u201364.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"1244_CR26","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00401-017-1693-y","volume":"133","author":"JS Yokoyama","year":"2017","unstructured":"Yokoyama JS, Karch CM, Fan CC, et al. Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia. Acta Neuropathol. 2017;133(5):825.","journal-title":"Acta Neuropathol"},{"issue":"7","key":"1244_CR27","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1001\/jamaneurol.2018.0372","volume":"75","author":"CM Karch","year":"2018","unstructured":"Karch CM, Wen N, Fan CC, et al. Selective genetic overlap between amyotrophic lateral sclerosis and diseases of the frontotemporal dementia spectrum. JAMA Neurol. 2018;75(7):860\u201375.","journal-title":"JAMA Neurol"},{"issue":"1","key":"1244_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1534\/genetics.116.193987","volume":"205","author":"D Brzyski","year":"2017","unstructured":"Brzyski D, Peterson CB, Sobczyk P, Cand\u00e8s EJ, Bogdan M, Sabatti C. Controlling the rate of GWAS false discoveries. Genetics. 2017;205(1):61.","journal-title":"Genetics"},{"key":"1244_CR29","doi-asserted-by":"publisher","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18(12). https:\/\/doi.org\/10.1016\/S1474-4422(19)30320-5.","DOI":"10.1016\/S1474-4422(19)30320-5"},{"issue":"3","key":"1244_CR30","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414\u201330.","journal-title":"Nat Genet"},{"issue":"7726","key":"1244_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203\u20139.","journal-title":"Nature"},{"key":"1244_CR32","doi-asserted-by":"publisher","unstructured":"Buniello A, MacArthur JAL, Cerezo M, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47(D1). https:\/\/doi.org\/10.1093\/nar\/gky1120.","DOI":"10.1093\/nar\/gky1120"},{"issue":"11","key":"1244_CR33","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ng.3406","volume":"47","author":"B Bulik-Sullivan","year":"2015","unstructured":"Bulik-Sullivan B, Finucane HK, Anttila V, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet. 2015;47(11):1236\u201341.","journal-title":"Nat Genet"},{"issue":"8","key":"1244_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/s41588-020-0653-y","volume":"52","author":"Z Ning","year":"2020","unstructured":"Ning Z, Pawitan Y, Shen X. High-definition likelihood inference of genetic correlations across human complex traits. Nat Genet. 2020;52(8):859\u201364.","journal-title":"Nat Genet"},{"issue":"6","key":"1244_CR35","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ajhg.2017.11.001","volume":"101","author":"Q Lu","year":"2017","unstructured":"Lu Q, Li B, Ou D, et al. A powerful approach to estimating annotation-stratified genetic covariance via GWAS summary statistics. Am J Hum Genet. 2017;101(6):939\u201364.","journal-title":"Am J Hum Genet"},{"key":"1244_CR36","doi-asserted-by":"publisher","unstructured":"Auton A, Brooks LD, Durbin RM, et al. A global reference for human genetic variation. Nature. 2015;526(7571). https:\/\/doi.org\/10.1038\/nature15393.","DOI":"10.1038\/nature15393"},{"key":"1244_CR37","doi-asserted-by":"publisher","unstructured":"Priv\u00e9 F, Arbel J, Aschard H, Vilhj\u00e1lmsson BJ. Identifying and correcting for misspecifications in GWAS summary statistics and polygenic scores. bioRxiv. Published online April 13, 2022:2021.03.29.437510. https:\/\/doi.org\/10.1101\/2021.03.29.437510.","DOI":"10.1101\/2021.03.29.437510"},{"key":"1244_CR38","doi-asserted-by":"publisher","unstructured":"Huang L, Rosen JD, Sun Q, et al. TOP-LD: a tool to explore linkage disequilibrium with TOPMed whole-genome sequence data. Am J Hum Genet. 2022. https:\/\/doi.org\/10.1016\/j.ajhg.2022.04.006.","DOI":"10.1016\/j.ajhg.2022.04.006"},{"issue":"7845","key":"1244_CR39","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-021-03205-y","volume":"590","author":"D Taliun","year":"2021","unstructured":"Taliun D, Harris DN, Kessler MD, et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature. 2021;590(7845):290\u20139.","journal-title":"Nature"},{"key":"1244_CR40","doi-asserted-by":"publisher","unstructured":"Dmitrienko A, Wiens BL, Tamhane AC, Wang X. Tree-structured gatekeeping tests in clinical trials with hierarchically ordered multiple objectives. Stat Med. 2007;26(12). https:\/\/doi.org\/10.1002\/sim.2716.","DOI":"10.1002\/sim.2716"},{"issue":"5","key":"1244_CR41","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10(5):e1004383.","journal-title":"PLoS Genet"},{"issue":"2","key":"1244_CR42","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/bioinformatics\/btv546","volume":"32","author":"JKP Tomaz Berisa","year":"2016","unstructured":"Tomaz Berisa JKP. Approximately independent linkage disequilibrium blocks in human populations. Bioinformatics. 2016;32(2):283.","journal-title":"Bioinformatics"},{"key":"1244_CR43","doi-asserted-by":"crossref","unstructured":"Wingo TS, Liu Y, Gerasimov ES, et al. Shared mechanisms across the major psychiatric and neurodegenerative diseases. Nat Commun. 2022;13(1):4314.","DOI":"10.1038\/s41467-022-31873-5"},{"key":"1244_CR44","doi-asserted-by":"crossref","unstructured":"Jansen IE, Savage JE, Watanabe K, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet. 2019;51(3):404\u201313.","DOI":"10.1038\/s41588-018-0311-9"},{"key":"1244_CR45","doi-asserted-by":"publisher","unstructured":"Foster EM, Dangla-Valls A, Lovestone S, Ribe EM, Buckley NJ. Clusterin in Alzheimer\u2019s disease: mechanisms, genetics, and lessons from other pathologies. Front Neurosci. 2019;0. https:\/\/doi.org\/10.3389\/fnins.2019.00164.","DOI":"10.3389\/fnins.2019.00164"},{"key":"1244_CR46","doi-asserted-by":"publisher","unstructured":"Bettens K, Brouwers N, Engelborghs S, et al. Both common variations and rare non-synonymous substitutions and small insertion\/deletions in CLU are associated with increased Alzheimer risk. Mol Neurodegener. 2012;7. https:\/\/doi.org\/10.1186\/1750-1326-7-3.","DOI":"10.1186\/1750-1326-7-3"},{"issue":"3","key":"1244_CR47","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/glia.23920","volume":"69","author":"A Filippini","year":"2021","unstructured":"Filippini A, Mutti V, Faustini G, et al. Extracellular clusterin limits the uptake of \u03b1-synuclein fibrils by murine and human astrocytes. Glia. 2021;69(3):681.","journal-title":"Glia"},{"issue":"6","key":"1244_CR48","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1038\/s41380-020-0725-5","volume":"26","author":"J Kummeling","year":"2020","unstructured":"Kummeling J, Stremmelaar DE, Raun N, et al. Characterization of SETD1A haploinsufficiency in humans and Drosophila defines a novel neurodevelopmental syndrome. Mol Psychiatry. 2020;26(6):2013\u201324.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"1244_CR49","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1172\/JCI131145","volume":"130","author":"L Li","year":"2020","unstructured":"Li L, Ghorbani M, Weisz-Hubshman M, et al. Lysine acetyltransferase 8 is involved in cerebral development and syndromic intellectual disability. J Clin Invest. 2020;130(3):1431.","journal-title":"J Clin Invest"},{"issue":"7463","key":"1244_CR50","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/nature12313","volume":"500","author":"J F\u00fcllgrabe","year":"2013","unstructured":"F\u00fcllgrabe J, Lynch-Day MA, Heldring N, et al. The histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy. Nature. 2013;500(7463):468.","journal-title":"Nature"},{"issue":"8","key":"1244_CR51","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1093\/brain\/awy147","volume":"141","author":"AD Klein","year":"2018","unstructured":"Klein AD, Mazzulli JR. Is Parkinson\u2019s disease a lysosomal disorder? Brain. 2018;141(8):2255\u201362.","journal-title":"Brain"},{"key":"1244_CR52","doi-asserted-by":"publisher","unstructured":"Soutar MPM, Melandri D, O\u2019Callaghan B, et al. Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson\u2019s disease at Chr16q11.2 and on the MAPT H1 allele. bioRxiv. 2021. https:\/\/doi.org\/10.1101\/2020.01.06.896241.","DOI":"10.1101\/2020.01.06.896241"},{"issue":"7886","key":"1244_CR53","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","volume":"599","author":"JD Backman","year":"2021","unstructured":"Backman JD, Li AH, Marcketta A, et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature. 2021;599(7886):628\u201334.","journal-title":"Nature"},{"key":"1244_CR54","doi-asserted-by":"publisher","unstructured":"Frankish A, Diekhans M, Jungreis I, et al. GENCODE 2021. Nucleic Acids Res. 2021;49(D1). https:\/\/doi.org\/10.1093\/nar\/gkaa1087.","DOI":"10.1093\/nar\/gkaa1087"},{"issue":"29","key":"1244_CR55","doi-asserted-by":"publisher","first-page":"30498","DOI":"10.1074\/jbc.M401399200","volume":"279","author":"CI Sze","year":"2004","unstructured":"Sze CI, Su M, Pugazhenthi S, et al. Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer\u2019s disease. J Biol Chem. 2004;279(29):30498\u2013506.","journal-title":"J Biol Chem"},{"issue":"6","key":"1244_CR56","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.18632\/oncotarget.2876","volume":"6","author":"JY Chang","year":"2015","unstructured":"Chang JY, Lee MH, Lin SR, et al. Trafficking protein particle complex 6A delta (TRAPPC6A\u0394) is an extracellular plaque-forming protein in the brain. Oncotarget. 2015;6(6):3578.","journal-title":"Oncotarget"},{"key":"1244_CR57","doi-asserted-by":"publisher","unstructured":"Lo CP, Hsu LJ, Li MY, et al. MPP+-induced neuronal death in rats involves tyrosine 33 phosphorylation of WW domain-containing oxidoreductase WOX1. Eur J Neurosci. 2008;27(7). https:\/\/doi.org\/10.1111\/j.1460-9568.2008.06139.x.","DOI":"10.1111\/j.1460-9568.2008.06139.x"},{"key":"1244_CR58","doi-asserted-by":"publisher","unstructured":"Root J, Merino P, Nuckols A, Johnson M, Kukar T. Lysosome dysfunction as a cause of neurodegenerative diseases: lessons from frontotemporal dementia and amyotrophic lateral sclerosis. Neurobiol Dis. 2021;154. https:\/\/doi.org\/10.1016\/j.nbd.2021.105360.","DOI":"10.1016\/j.nbd.2021.105360"},{"issue":"11","key":"1244_CR59","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41582-020-00423-2","volume":"16","author":"I Fyfe","year":"2020","unstructured":"Fyfe I. Potential gene therapy for FTD. Nat Rev Neurol. 2020;16(11):600\u2013600.","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"1244_CR60","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrn.2017.36","volume":"18","author":"AW Kao","year":"2017","unstructured":"Kao AW, McKay A, Singh PP, Brunet A, Huang EJ. Progranulin, lysosomal regulation and neurodegenerative disease. Nat Rev Neurosci. 2017;18(6):325\u201333.","journal-title":"Nat Rev Neurosci"},{"key":"1244_CR61","doi-asserted-by":"publisher","unstructured":"Davis SE, Roth JR, Aljabi Q, et al. Delivering progranulin to neuronal lysosomes protects against excitotoxicity. J Biol Chem. 2021;297(3). https:\/\/doi.org\/10.1016\/j.jbc.2021.100993.","DOI":"10.1016\/j.jbc.2021.100993"},{"key":"1244_CR62","doi-asserted-by":"publisher","unstructured":"Xu W, Han SD, Zhang C, et al. The FAM171A2 gene is a key regulator of progranulin expression and modifies the risk of multiple neurodegenerative diseases. Sci Adv. 2020;6(43). https:\/\/doi.org\/10.1126\/sciadv.abb3063.","DOI":"10.1126\/sciadv.abb3063"},{"issue":"11","key":"1244_CR63","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s12031-020-01776-5","volume":"71","author":"L Pan","year":"2021","unstructured":"Pan L, Meng L, He M, Zhang Z. Tau in the pathophysiology of Parkinson\u2019s disease. J Mol Neurosci. 2021;71(11):2179\u201391.","journal-title":"J Mol Neurosci"},{"issue":"7","key":"1244_CR64","doi-asserted-by":"publisher","first-page":"e47630","DOI":"10.15252\/embr.201847630","volume":"20","author":"BN Sheikh","year":"2019","unstructured":"Sheikh BN, Guhathakurta S, Akhtar A. The non-specific lethal (NSL) complex at the crossroads of transcriptional control and cellular homeostasis. EMBO Rep. 2019;20(7):e47630.","journal-title":"EMBO Rep"},{"issue":"1","key":"1244_CR65","first-page":"1","volume":"13","author":"T Li","year":"2022","unstructured":"Li T, Lu D, Yao C, et al. Kansl1 haploinsufficiency impairs autophagosome-lysosome fusion and links autophagic dysfunction with Koolen-de Vries syndrome in mice. Nat Commun. 2022;13(1):1\u201316.","journal-title":"Nat Commun"},{"issue":"2","key":"1244_CR66","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/15548627.2021.1936777","volume":"18","author":"K Linda","year":"2022","unstructured":"Linda K, Lewerissa EI, Verboven AHA, et al. Imbalanced autophagy causes synaptic deficits in a human model for neurodevelopmental disorders. Autophagy. 2022;18(2):423\u201342. https:\/\/doi.org\/10.1080\/15548627.2021.1936777.","journal-title":"Autophagy"},{"issue":"1","key":"1244_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-00471-1","volume":"8","author":"B Benyamin","year":"2017","unstructured":"Benyamin B, He J, Zhao Q, et al. Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis. Nat Commun. 2017;8(1):1\u20137.","journal-title":"Nat Commun"},{"key":"1244_CR68","doi-asserted-by":"publisher","unstructured":"Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362(6415). https:\/\/doi.org\/10.1038\/362059a0.","DOI":"10.1038\/362059a0"},{"key":"1244_CR69","doi-asserted-by":"publisher","unstructured":"Tanaka H, Shimazawa M, Takata M, et al. ITIH4 and Gpx3 are potential biomarkers for amyotrophic lateral sclerosis. J Neurol. 2013;260(7). https:\/\/doi.org\/10.1007\/s00415-013-6877-3.","DOI":"10.1007\/s00415-013-6877-3"},{"issue":"1","key":"1244_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-021-01006-6","volume":"14","author":"R Restuadi","year":"2022","unstructured":"Restuadi R, Steyn FJ, Kabashi E, et al. Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3\/TNIP1. Genome Med. 2022;14(1):1\u201322.","journal-title":"Genome Med"},{"issue":"21","key":"1244_CR71","doi-asserted-by":"publisher","first-page":"8065","DOI":"10.1074\/jbc.RA117.000490","volume":"293","author":"A Gauthier-Kemper","year":"2018","unstructured":"Gauthier-Kemper A, Alonso MS, S\u00fcndermann F, et al. Annexins A2 and A6 interact with the extreme N terminus of tau and thereby contribute to tau\u2019s axonal localization. J Biol Chem. 2018;293(21):8065.","journal-title":"J Biol Chem"},{"issue":"2\u20133","key":"1244_CR72","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0925-4439(99)00074-5","volume":"1455","author":"DJ Mahuran","year":"1999","unstructured":"Mahuran DJ. Biochemical consequences of mutations causing the GM2 gangliosidoses. Biochim Biophys Acta. 1999;1455(2\u20133):105\u201338.","journal-title":"Biochim Biophys Acta"},{"issue":"23","key":"1244_CR73","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1002\/1873-3468.13082","volume":"592","author":"A Ma\u00efza","year":"2018","unstructured":"Ma\u00efza A, Chantepie S, Vera C, et al. The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration. FEBS Lett. 2018;592(23):3806\u201318.","journal-title":"FEBS Lett"},{"issue":"27","key":"1244_CR74","doi-asserted-by":"publisher","first-page":"10826","DOI":"10.1074\/jbc.RA117.000378","volume":"293","author":"BE Stopschinski","year":"2018","unstructured":"Stopschinski BE, Holmes BB, Miller GM, et al. Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau versus \u03b1-synuclein and \u03b2-amyloid aggregates. J Biol Chem. 2018;293(27):10826.","journal-title":"J Biol Chem"},{"issue":"5","key":"1244_CR75","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1002\/anie.201913029","volume":"59","author":"J Zhao","year":"2020","unstructured":"Zhao J, Zhu Y, Song X, et al. Rare 3-O-sulfation of heparan sulfate enhances tau interaction and cellular uptake. Angew Chem Int Ed Engl. 2020;59(5):1818.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1244_CR76","doi-asserted-by":"crossref","unstructured":"Guan JS, Haggarty SJ, Giacometti E, et al. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature. 2009;459(7243):55\u201360.","DOI":"10.1038\/nature07925"},{"issue":"7388","key":"1244_CR77","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10849","volume":"483","author":"J Gr\u00e4ff","year":"2012","unstructured":"Gr\u00e4ff J, Rei D, Guan JS, et al. An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature. 2012;483(7388):222\u20136.","journal-title":"Nature"},{"issue":"1","key":"1244_CR78","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/acn3.147","volume":"2","author":"A Didonna","year":"2015","unstructured":"Didonna A, Opal P. The promise and perils of HDAC inhibitors in neurodegeneration. Ann Clin Transl Neurol. 2015;2(1):79.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"1244_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-019-0750-2","volume":"7","author":"E Rossaert","year":"2019","unstructured":"Rossaert E, Pollari E, Jaspers T, et al. Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model. Acta Neuropathol Commun. 2019;7(1):1\u201319.","journal-title":"Acta Neuropathol Commun"},{"key":"1244_CR80","doi-asserted-by":"publisher","unstructured":"Tagawa K, Homma H, Saito A, et al. Comprehensive phosphoproteome analysis unravels the core signaling network that initiates the earliest synapse pathology in preclinical Alzheimer\u2019s disease brain. Hum Mol Genet. 2015;24(2). https:\/\/doi.org\/10.1093\/hmg\/ddu475.","DOI":"10.1093\/hmg\/ddu475"},{"issue":"1","key":"1244_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep31895","volume":"6","author":"K Fujita","year":"2016","unstructured":"Fujita K, Motoki K, Tagawa K, et al. HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer\u2019s disease. Sci Rep. 2016;6(1):1\u201315.","journal-title":"Sci Rep"},{"issue":"1","key":"1244_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-14353-6","volume":"11","author":"H Tanaka","year":"2020","unstructured":"Tanaka H, Homma H, Fujita K, et al. YAP-dependent necrosis occurs in early stages of Alzheimer\u2019s disease and regulates mouse model pathology. Nat Commun. 2020;11(1):1\u201322.","journal-title":"Nat Commun"},{"key":"1244_CR83","doi-asserted-by":"publisher","unstructured":"Fujita K, Homma H, Kondo K, et al. Ser46-phosphorylated MARCKS is a marker of neurite degeneration at the pre-aggregation stage in PD\/DLB pathology. eNeuro. 2018;5(4). https:\/\/doi.org\/10.1523\/ENEURO.0217-18.2018.","DOI":"10.1523\/ENEURO.0217-18.2018"},{"issue":"1","key":"1244_CR84","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s12035-021-02557-w","volume":"59","author":"T Petrozziello","year":"2021","unstructured":"Petrozziello T, Bordt EA, Mills AN, et al. Targeting tau mitigates mitochondrial fragmentation and oxidative stress in amyotrophic lateral sclerosis. Mol Neurobiol. 2021;59(1):683\u2013702.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"1244_CR85","doi-asserted-by":"publisher","first-page":"e13035","DOI":"10.1111\/bpa.13035","volume":"32","author":"T Petrozziello","year":"2022","unstructured":"Petrozziello T, Amaral AC, Dujardin S, et al. Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post-mortem motor cortex and cerebrospinal fluid. Brain Pathol. 2022;32(2):e13035.","journal-title":"Brain Pathol"},{"key":"1244_CR86","doi-asserted-by":"publisher","unstructured":"Gali\u00e8gue S, Jbilo O, Combes T, et al. Cloning and characterization of PRAX-1. A new protein that specifically interacts with the peripheral benzodiazepine receptor. J Biol Chem. 1999;274(5). https:\/\/doi.org\/10.1074\/jbc.274.5.2938.","DOI":"10.1074\/jbc.274.5.2938"},{"issue":"12","key":"1244_CR87","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nrd3295","volume":"9","author":"R Rupprecht","year":"2010","unstructured":"Rupprecht R, Papadopoulos V, Rammes G, et al. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov. 2010;9(12):971\u201388.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"1244_CR88","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2967\/jnumed.114.141713","volume":"57","author":"L Vivash","year":"2016","unstructured":"Vivash L, O\u2019Brien TJ. Imaging microglial activation with TSPO PET: lighting up neurologic diseases? J Nucl Med. 2016;57(2):165\u20138.","journal-title":"J Nucl Med"},{"issue":"20","key":"1244_CR89","doi-asserted-by":"publisher","first-page":"8891","DOI":"10.1523\/JNEUROSCI.1350-13.2013","volume":"33","author":"AM Barron","year":"2013","unstructured":"Barron AM, Garcia-Segura LM, Caruso D, et al. Ligand for translocator protein reverses Pathology in a mouse model of Alzheimer\u2019s disease. J Neurosci. 2013;33(20):8891.","journal-title":"J Neurosci"},{"issue":"1","key":"1244_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-021-02122-1","volume":"18","author":"LH Fairley","year":"2021","unstructured":"Fairley LH, Sahara N, Aoki I, et al. Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy. J Neuroinflammation. 2021;18(1):1\u201313.","journal-title":"J Neuroinflammation"},{"issue":"7","key":"1244_CR91","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1073\/pnas.1318306111","volume":"111","author":"A Beilina","year":"2014","unstructured":"Beilina A, Rudenko IN, Kaganovich A, et al. From the cover: unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease. Proc Natl Acad Sci U S A. 2014;111(7):2626.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1244_CR92","doi-asserted-by":"publisher","unstructured":"Song L, He Y, Ou J, et al. Auxilin underlies progressive locomotor deficits and dopaminergic neuron loss in a Drosophila model of Parkinson\u2019s disease. Cell Rep. 2017;18(5). https:\/\/doi.org\/10.1016\/j.celrep.2017.01.005.","DOI":"10.1016\/j.celrep.2017.01.005"},{"key":"1244_CR93","doi-asserted-by":"publisher","unstructured":"Zhang S, Wang L, Yi S, et al. Cyclin-G-associated kinase GAK\/Aux orchestrates glial autophagy via Atg9 phosphorylation in Parkinson\u2019s disease. bioRxiv. 2021. https:\/\/doi.org\/10.1101\/2021.08.16.456579.","DOI":"10.1101\/2021.08.16.456579"},{"issue":"9","key":"1244_CR94","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1073\/pnas.1616332114","volume":"114","author":"S Jinn","year":"2017","unstructured":"Jinn S, Drolet RE, Cramer PE, et al. TMEM175 deficiency impairs lysosomal and mitochondrial function and increases \u03b1-synuclein aggregation. Proc Natl Acad Sci U S A. 2017;114(9):2389\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"1244_CR95","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1093\/hmg\/ddz136","volume":"28","author":"S Jinn","year":"2019","unstructured":"Jinn S, Blauwendraat C, Toolan D, et al. Functionalization of the TMEM175 p.M393T variant as a risk factor for Parkinson disease. Hum Mol Genet. 2019;28(19):3244\u201354.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"1244_CR96","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/ng.3626","volume":"48","author":"KP Kenna","year":"2016","unstructured":"Kenna KP, van Doormaal PTC, Dekker AM, et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat Genet. 2016;48(9):1037.","journal-title":"Nat Genet"},{"issue":"15","key":"1244_CR97","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.1007\/s00018-021-03872-0","volume":"78","author":"JR Kok","year":"2021","unstructured":"Kok JR, Palminha NM, Dos Santos SC, El-Khamisy SF, Ferraiuolo L. DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity. Cell Mol Life Sci. 2021;78(15):5707\u201329.","journal-title":"Cell Mol Life Sci"},{"key":"1244_CR98","doi-asserted-by":"publisher","unstructured":"Higelin J, Catanese A, Semelink-Sedlacek LL, et al. NEK1 loss-of-function mutation induces DNA damage accumulation in ALS patient-derived motoneurons. Stem Cell Res. 2018;30. https:\/\/doi.org\/10.1016\/j.scr.2018.06.005.","DOI":"10.1016\/j.scr.2018.06.005"},{"issue":"1","key":"1244_CR99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20314-w","volume":"12","author":"H Wang","year":"2021","unstructured":"Wang H, Qi W, Zou C, et al. NEK1-mediated retromer trafficking promotes blood\u2013brain barrier integrity by regulating glucose metabolism and RIPK1 activation. Nat Commun. 2021;12(1):1\u201319.","journal-title":"Nat Commun"},{"key":"1244_CR100","doi-asserted-by":"publisher","unstructured":"Freund MK, Burch KS, Shi H, et al. Phenotype-specific enrichment of mendelian disorder genes near GWAS regions across 62 complex traits. Am J Hum Genet. 2018;103(4). https:\/\/doi.org\/10.1016\/j.ajhg.2018.08.017.","DOI":"10.1016\/j.ajhg.2018.08.017"},{"key":"1244_CR101","doi-asserted-by":"publisher","unstructured":"Lumsden AL, Mulugeta A, Zhou A, Hypp\u00f6nen E. Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK Biobank. EBioMedicine. 2020;59. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102954.","DOI":"10.1016\/j.ebiom.2020.102954"},{"issue":"4","key":"1244_CR102","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41588-019-0385-z","volume":"51","author":"M Wainberg","year":"2019","unstructured":"Wainberg M, Sinnott-Armstrong N, Mancuso N, et al. Opportunities and challenges for transcriptome-wide association studies. Nat Genet. 2019;51(4):592\u20139.","journal-title":"Nat Genet"},{"issue":"1","key":"1244_CR103","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1093\/nar\/gky837","volume":"47","author":"D Stacey","year":"2019","unstructured":"Stacey D, Fauman EB, Ziemek D, et al. ProGeM: a framework for the prioritization of candidate causal genes at molecular quantitative trait loci. Nucleic Acids Res. 2019;47(1):e3.","journal-title":"Nucleic Acids Res"},{"issue":"40","key":"1244_CR104","doi-asserted-by":"publisher","first-page":"13568","DOI":"10.1523\/JNEUROSCI.2468-15.2015","volume":"35","author":"O Levy","year":"2015","unstructured":"Levy O, Lavalette S, Hu SJ, et al. APOE isoforms control pathogenic subretinal inflammation in age-related macular degeneration. J Neurosci. 2015;35(40):13568.","journal-title":"J Neurosci"},{"issue":"9","key":"1244_CR105","doi-asserted-by":"publisher","first-page":"e1009440","DOI":"10.1371\/journal.pgen.1009440","volume":"17","author":"C Wallace","year":"2021","unstructured":"Wallace C. A more accurate method for colocalisation analysis allowing for multiple causal variants. PLoS Genet. 2021;17(9):e1009440.","journal-title":"PLoS Genet"},{"issue":"3","key":"1244_CR106","doi-asserted-by":"publisher","first-page":"fcac125","DOI":"10.1093\/braincomms\/fcac125","volume":"4","author":"V Escott-Price","year":"2022","unstructured":"Escott-Price V, Hardy J. Genome-wide association studies for Alzheimer\u2019s disease: bigger is not always better. Brain Commun. 2022;4(3):fcac125.","journal-title":"Brain Commun"},{"issue":"1","key":"1244_CR107","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","volume":"23","author":"GB Frisoni","year":"2021","unstructured":"Frisoni GB, Altomare D, Thal DR, et al. The probabilistic model of Alzheimer disease: the amyloid hypothesis revised. Nat Rev Neurosci. 2021;23(1):53\u201366.","journal-title":"Nat Rev Neurosci"},{"issue":"7145","key":"1244_CR108","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature05911","volume":"447","author":"Wellcome Trust Case Control Consortium","year":"2007","unstructured":"Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661\u201378.","journal-title":"Nature"},{"issue":"1","key":"1244_CR109","doi-asserted-by":"publisher","first-page":"190221","DOI":"10.1098\/rsob.190221","volume":"10","author":"RV Broekema","year":"2020","unstructured":"Broekema RV, Bakker OB, Jonkers IH. A practical view of fine-mapping and gene prioritization in the post-genome-wide association era. Open Biol. 2020;10(1):190221.","journal-title":"Open Biol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-023-01244-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-023-01244-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-023-01244-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T05:08:41Z","timestamp":1686892121000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-023-01244-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":109,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1244"],"URL":"https:\/\/doi.org\/10.1186\/s13195-023-01244-3","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]},"assertion":[{"value":"19 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from participants in the AD, ADRD, PD, and ALS GWAS by the original GWAS studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to the publication of this manuscript. This study exclusively uses GWAS summary statistics and does not rely on any individual-level data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}